Medicaid Generic Drug Price Fairness Act of 2015
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 22, 2015
Referred to the Subcommittee on Health.
May 18, 2015
Referred to the House Committee on Energy and Commerce.
May 18, 2015
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Medicaid Generic Drug Price Fairness Act of 2015
This bill amends title XIX (Medicaid) of the Social Security Act to increase the amount of rebate with respect to each generic drug in the manner that the rebate for a dosage form and strength of a single source drug or an innovator multiple source drug is increased, except as provided in special application rules, including a special rule for certain noninnovator multiple source drugs.
What's happening now
Referred to the Subcommittee on Health.
Related & companion bills
3
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
2
Cosponsors
2
Cite this page
U.S. Congress. (2026). H.R. 2391: Medicaid Generic Drug Price Fairness Act of 2015. 114th Congress. Open America. https://openamerica.io/bill/114-HR-2391/
"H.R. 2391: Medicaid Generic Drug Price Fairness Act of 2015." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-2391/.
H.R. 2391, 114th Cong. (2026), https://openamerica.io/bill/114-HR-2391/.
[H.R. 2391: Medicaid Generic Drug Price Fairness Act of 2015](https://openamerica.io/bill/114-HR-2391/)